Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1994 Jan;170(1 Pt 1):85-9.
doi: 10.1016/s0002-9378(94)70389-2.

Antenatal vitamin K therapy of the low-birth-weight infant

R C Dickson  1 , T M Stubbs, J Lazarchick
Affiliations
Clinical Trial

Antenatal vitamin K therapy of the low-birth-weight infant

R C Dickson et al. Am J Obstet Gynecol. 1994 Jan.

Abstract

Objective: The purpose of our study was to determine whether maternal vitamin K1 administered antenatally improved global coagulation parameters and the levels of specific vitamin K-dependent proteins in low-birth-weight infants.

Study design: Thirty-three preterm mothers admitted in labor were assigned in a prospective, blinded fashion to receive either intramuscular vitamin K1 (17) or placebo (16). At delivery cord blood samples were tested for prothrombin time, activated partial thromboplastin time, factor II and protein C activity, and antigen levels. Statistical analysis was by Student t test.

Results: No statistically significant differences could be demonstrated with regard to group mean values for global tests (prothrombin time, activated partial thromboplastin time) or specific vitamin K-dependent protein levels (factor II, protein C) in newborns whose mothers received antenatal vitamin K compared with those who did not.

Conclusion: These results would suggest that antenatal vitamin K1 therapy to mothers < 32 weeks' gestation has no significant effect on the level of vitamin K-dependent factors in the fetus.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates.
    Ardell S, Offringa M, Ovelman C, Soll R. Ardell S, et al. Cochrane Database Syst Rev. 2018 Feb 5;2(2):CD008342. doi: 10.1002/14651858.CD008342.pub2. Cochrane Database Syst Rev. 2018. PMID: 29401369 Free PMC article.
  • Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage.
    Crowther CA, Crosby DD, Henderson-Smart DJ. Crowther CA, et al. Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000229. doi: 10.1002/14651858.CD000229.pub2. Cochrane Database Syst Rev. 2010. PMID: 20091505 Free PMC article.
  • Current concepts and controversies in the use of vitamin K.
    Thorp JA, Gaston L, Caspers DR, Pal ML. Thorp JA, et al. Drugs. 1995 Mar;49(3):376-87. doi: 10.2165/00003495-199549030-00005. Drugs. 1995. PMID: 7774512 Review.
  • Dietary reference values for vitamin K.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Turck D, Bresson JL, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Nowicka G, Pentieva K, Sanz Y, Siani A, Sjödin A, Stern M, Tomé D, Van Loveren H, Vinceti M, Willatts P, Lamberg-Allardt C, Przyrembel H, Tetens I, Dumas C, Fabiani L, Ioannidou S, Neuhäuser-Berthold M. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al. EFSA J. 2017 May 22;15(5):e04780. doi: 10.2903/j.efsa.2017.4780. eCollection 2017 May. EFSA J. 2017. PMID: 32625486 Free PMC article.

Publication types

MeSH terms